Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review
F Peytam, Z Emamgholipour, A Mousavi, M Moradi… - Bioorganic …, 2023 - Elsevier
Considering the fundamental role of protein kinases in the mechanism of protein
phosphorylation in critical cellular processes, their dysregulation, especially in cancers, has …
phosphorylation in critical cellular processes, their dysregulation, especially in cancers, has …
Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach
Alzheimer's disease (AD) is an enigmatic neurological illness that offers few treatment
options. Recent exploration has highlighted the crucial connection of the Wnt signaling …
options. Recent exploration has highlighted the crucial connection of the Wnt signaling …
Green synthesized extracts/Au complex of Phyllospongia lamellosa: Unrevealing the anti-cancer and anti-bacterial potentialities, supported by metabolomics and …
The anti-cancer and anti-bacterial potential of the Red Sea sponge Phyllospongia lamellosa
in its bulk (crude extracts) and gold nanostructure (loaded on gold nanaoparticles) were …
in its bulk (crude extracts) and gold nanostructure (loaded on gold nanaoparticles) were …
Identification of a novel GSK3β inhibitor involved in abrogating KRas dependent pancreatic tumors in Wnt/beta-catenin and NF-kB dependent manner
Pancreatic cancer is an aggressive malignancy with a poor survival rate because it is difficult
to diagnose the disease during its early stages. The currently available treatments, which …
to diagnose the disease during its early stages. The currently available treatments, which …
Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator
D Karati, S Mukherjee, S Roy - Medical Oncology, 2024 - Springer
In developing new cancer medications, attention has been focused on novel epigenetic
medicines called histone deacetylase (HDAC) inhibitors. Our understanding of cancer …
medicines called histone deacetylase (HDAC) inhibitors. Our understanding of cancer …